Grapevine: True North-backed Anthem Bio mulls IPO; CVC Capital India head resigns
Advertisement

Grapevine: True North-backed Anthem Bio mulls IPO; CVC Capital India head resigns

By Sreeja Biswas

  • 10 Jul 2024
Premium
Grapevine: True North-backed Anthem Bio mulls IPO; CVC Capital India head resigns
Credit: 123RF.com

Anthem Biosciences Pvt Ltd, a Bengaluru-based contract drug researcher and manufacturer, is contemplating an initial public offering (IPO) in India that could raise about $400 million (Rs 3340 crore), a media report said.   VCCircle first reported that Anthem is looking to snag $50-70 million in fresh funding as it gears up for an IPO.   Indian private equity ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement